Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Sidney Brevard

Trauma Surgery Mobile, AL Medical Doctor

NPI 1487675740 CMS profile 604675

2451 Fillingim St, Mobile, AL 36617

Open in the dashboard

General payments

$3,837

56 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Sidney Brevard of Mobile, AL is reported in the CMS Open Payments database as having received $3,837 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 64th percentile of Trauma Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $20 1
2022 General $117 4
2021 General $564 12
2020 General $2,594 13
2019 General $541 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sidney Brevard
  • Trauma Surgery median
  • Middle half of Trauma Surgery
  • National median

In program year 2025, general payments to Sidney Brevard were reported at $0. Among 762 Trauma Surgery profiles paid that year, the median was $280 and the middle half received between $87 and $1,585.

Show as a table
Year Sidney Brevard Trauma Surgery median Middle half National median
2019 $541 $153 $56–$644 $163
2020 $2,594 $123 $39–$342 $114
2021 $564 $142 $45–$556 $132
2022 $117 $172 $59–$732 $149
2023 $20 $213 $83–$1,200 $160
2024 $0 $237 $86–$1,280 $164
2025 $0 $280 $87–$1,585 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Portola Pharmaceuticals, Inc. $2,410 4 payments
  2. DePuy Synthes Sales Inc. $441 18 payments
  3. Baxter Healthcare $184 6 payments
  4. Kerecis Limited $141 1 payment
  5. Smith+Nephew, Inc. $128 2 payments
  6. Avita Medical Americas, LLC $62 1 payment
  7. PolarityTE, Inc. $61 1 payment
  8. Z-Medica, LLC $47 3 payments
  9. Merck Sharp & Dohme Corporation $46 3 payments
  10. Medela LLC $38 2 payments
  11. Other $279 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Honoraria $2,250 1 payment
  2. Food and Beverage $1,541 52 payments
  3. Consulting Fee $30 2 payments
  4. Travel and Lodging $16 1 payment
Products named General payments · program years 2019–2023
  1. ANDEXXA $2,410 4 payments
  2. MATRIXRIB CMF-Trauma $202 6 payments
  3. ARTISS $184 6 payments
  4. Kerecis Omega3 Wound $141 1 payment
  5. Kerecis Omega3 Surgibind $141 1 payment
  6. Kerecis Omega3 GraftGuide $141 1 payment
  7. Kerecis Omega3 SurgiClose $141 1 payment
  8. MATRIXRIB CMF-Trauma $137 7 payments
  9. COLLAGENASE SANTYL $112 1 payment
  10. XCM BIOLOGIC $80 4 payments
  11. Other $656 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Trauma Surgery in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record